Table 4

Prespecified adverse clinical outcomes in the CMR substudy participants

CharacteristicCulprit-artery-only PCI
n=42 (50%)
Preventive PCI
n=42 (50%)
Primary outcome*
 Death from cardiac causes, non-fatal myocardial infarction or refractory angina74
 Death from cardiac causes or non-fatal myocardial infarction42
 Death from cardiac causes20
 Non-fatal myocardial infarction22
 Refractory angina32
Secondary outcomes*
 Death from non-cardiac causes22
 Repeat revascularisation43
  • In line with the preventive angioplasty in myocardial infarction (PRAMI) protocol11 the study participants underwent standard care follow-up led by the attending physician. Routine stress testing was not performed and instead stress tests and repeat revascularisation during follow-up were clinically indicated based on a history of angina in line with contemporary guidelines.

  • *The follow-up interval is from randomisation to 1 December 2015.

  • CMR, cardiac magnetic resonance; PCI, percutaneous coronary intervention.